• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

UHRF1 的过表达与喉鳞状细胞癌的不良预后显著相关。

Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.

机构信息

Department of Otolaryngology, The First Affiliated Hospital of Chongqing Medical University, No. 1 Youyi Road, Chongqing, 400016, People's Republic of China.

出版信息

Med Oncol. 2013 Dec;30(4):613. doi: 10.1007/s12032-013-0613-9. Epub 2013 Sep 5.

DOI:10.1007/s12032-013-0613-9
PMID:24005809
Abstract

The ubiquitin-like with PHD and ring finger domains 1 (UHRF1) has been reported to be essential for cell proliferation and plays a critical role in the development and progression of many human carcinomas. However, its clinical and prognostic significance in laryngeal squamous cell carcinoma (LSCC) remains unclear. In the current study, 60 patients with LSCC were studied. UHRF1 expression at mRNA and protein levels was detected by quantitative reverse transcriptase-polymerase chain reaction (qRT-PCR) and immunohistochemistry, respectively, in both tissues of LSCC and corresponding adjacent normal larynx tissues. Statistical analyses were conducted to test the correlations between UHRF1 expression, clinicopathological parameters, and prognosis. qRT-PCR showed that the expression of UHRF1 mRNA in LSCC tissues was significantly higher than that in adjacent normal larynx tissues (P < 0.001). By immunohistochemistry, overexpression of UHRF1 protein was found in 78.3% (47/60) of the LSCC tissues, while there was negative expression in adjacent normal larynx tissues. Furthermore, increased expression of UHRF1 had remarkably positive relationships with smoking (P < 0.001), advanced T stage (P = 0.005) and clinical stage (P = 0.044), poor histological differentiation (P = 0.048), while there was no correlations between UHRF1, and sex, age and lymph node metastasis (P > 0.05). Overexpression of UHRF1 was also associated with worse overall survival examined by Kaplan-Meier method (P = 0.036). Multivariate analysis showed that increased expression of UHRF1 was an independent prognostic factor for LSCC (P = 0.013). Therefore, overexpression of UHRF1 may play an important role in the development and progression of LSCC, and UHRF1 might be a useful biomarker for the prognosis of LSCC.

摘要

泛素样含 PH 和环指结构域蛋白 1(UHRF1)已被报道对细胞增殖至关重要,并在许多人类癌的发生和发展中发挥关键作用。然而,其在喉鳞状细胞癌(LSCC)中的临床和预后意义尚不清楚。在本研究中,研究了 60 例 LSCC 患者。通过定量逆转录聚合酶链反应(qRT-PCR)和免疫组织化学分别检测 LSCC 组织和相应的相邻正常喉组织中 UHRF1 的 mRNA 和蛋白水平表达。进行统计学分析以检验 UHRF1 表达与临床病理参数和预后之间的相关性。qRT-PCR 显示 LSCC 组织中 UHRF1 mRNA 的表达明显高于相邻正常喉组织(P <0.001)。通过免疫组织化学,发现 78.3%(47/60)的 LSCC 组织中 UHRF1 蛋白呈过表达,而相邻正常喉组织呈阴性表达。此外,UHRF1 表达增加与吸烟(P <0.001)、晚期 T 分期(P = 0.005)和临床分期(P = 0.044)、组织学分化不良(P = 0.048)显著正相关,而与 UHRF1 与性别、年龄和淋巴结转移无相关性(P >0.05)。Kaplan-Meier 法检查发现 UHRF1 过表达与总生存率降低有关(P = 0.036)。多变量分析显示,UHRF1 表达增加是 LSCC 的独立预后因素(P = 0.013)。因此,UHRF1 的过表达可能在 LSCC 的发生和发展中起重要作用,UHRF1 可能是 LSCC 预后的有用标志物。

相似文献

1
Overexpression of UHRF1 is significantly associated with poor prognosis in laryngeal squamous cell carcinoma.UHRF1 的过表达与喉鳞状细胞癌的不良预后显著相关。
Med Oncol. 2013 Dec;30(4):613. doi: 10.1007/s12032-013-0613-9. Epub 2013 Sep 5.
2
Alpha B-crystallin is a new prognostic marker for laryngeal squamous cell carcinoma.αB-晶状体蛋白是喉鳞状细胞癌的一个新的预后标志物。
J Exp Clin Cancer Res. 2012 Dec 12;31(1):101. doi: 10.1186/1756-9966-31-101.
3
Downregulation of miR-29c-3p is associated with a poor prognosis in patients with laryngeal squamous cell carcinoma.miR-29c-3p 的下调与喉鳞状细胞癌患者的不良预后相关。
Diagn Pathol. 2019 Oct 15;14(1):109. doi: 10.1186/s13000-019-0893-2.
4
Expression of paxillin in laryngeal squamous cell carcinoma and its prognostic value.桩蛋白在喉鳞状细胞癌中的表达及其预后价值。
Int J Clin Exp Pathol. 2015 Aug 1;8(8):9232-9. eCollection 2015.
5
HOX genes: potential candidates for the progression of laryngeal squamous cell carcinoma.HOX基因:喉鳞状细胞癌进展的潜在候选因素。
Tumour Biol. 2016 Nov;37(11):15087-15096. doi: 10.1007/s13277-016-5356-8. Epub 2016 Sep 22.
6
Expression and clinical significance of SIAH in laryngeal squamous cell carcinoma.SIAH 在喉鳞状细胞癌中的表达及临床意义。
Med Oncol. 2013 Mar;30(1):485. doi: 10.1007/s12032-013-0485-z. Epub 2013 Feb 9.
7
Expression and prognostic value of MAGE-A9 in laryngeal squamous cell carcinoma.MAGE-A9在喉鳞状细胞癌中的表达及预后价值
Int J Clin Exp Pathol. 2014 Sep 15;7(10):6734-42. eCollection 2014.
8
Long non-coding RNA profiling in laryngeal squamous cell carcinoma and its clinical significance: potential biomarkers for LSCC.喉鳞状细胞癌中的长链非编码RNA谱分析及其临床意义:喉鳞状细胞癌的潜在生物标志物
PLoS One. 2014 Sep 22;9(9):e108237. doi: 10.1371/journal.pone.0108237. eCollection 2014.
9
[Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].[星形胶质细胞上调基因-1蛋白在喉鳞状细胞癌中的表达及其临床意义]
Zhonghua Bing Li Xue Za Zhi. 2013 Feb;42(2):111-5. doi: 10.3760/cma.j.issn.0529-5807.2013.02.009.
10
High BAX/BCL2 mRNA ratio predicts favorable prognosis in laryngeal squamous cell carcinoma, particularly in patients with negative lymph nodes at the time of diagnosis.高BAX/BCL2 mRNA比值预示着喉鳞状细胞癌的预后良好,尤其是在诊断时淋巴结阴性的患者中。
Clin Biochem. 2016 Aug;49(12):890-6. doi: 10.1016/j.clinbiochem.2016.04.010. Epub 2016 Apr 26.

引用本文的文献

1
UHRF1 phase separation mediates stable inheritance of DNA methylation and promotes the proliferation of prostate cancer cells.UHRF1相分离介导DNA甲基化的稳定遗传并促进前列腺癌细胞的增殖。
Cell Commun Signal. 2025 Jun 20;23(1):297. doi: 10.1186/s12964-025-02309-6.
2
DNA Methylation Readers and Cancer: Mechanistic and Therapeutic Applications.DNA甲基化读取蛋白与癌症:机制及治疗应用
Front Oncol. 2019 Jun 11;9:489. doi: 10.3389/fonc.2019.00489. eCollection 2019.
3
UHRF1 suppression promotes cell differentiation and reduces inflammatory reaction in anaplastic thyroid cancer.

本文引用的文献

1
[Incidence and mortality of larynx cancer in China during 2003-2007].2003 - 2007年中国喉癌的发病率与死亡率
Zhonghua Liu Xing Bing Xue Za Zhi. 2012 Apr;33(4):395-8.
2
The SRA protein UHRF1 promotes epigenetic crosstalks and is involved in prostate cancer progression.SRA 蛋白 UHRF1 促进表观遗传串扰,并参与前列腺癌的进展。
Oncogene. 2012 Nov 15;31(46):4878-87. doi: 10.1038/onc.2011.641. Epub 2012 Feb 13.
3
UHRF1 promotes cell growth and metastasis through repression of p16(ink⁴a) in colorectal cancer.UHRF1 通过抑制结直肠癌细胞中的 p16(ink⁴a)促进细胞生长和转移。
UHRF1抑制促进间变性甲状腺癌中的细胞分化并减少炎症反应。
Oncotarget. 2016 Jul 18;9(62):31945-31957. doi: 10.18632/oncotarget.10674. eCollection 2018 Aug 10.
4
Targeting the SET and RING-associated (SRA) domain of ubiquitin-like, PHD and ring finger-containing 1 (UHRF1) for anti-cancer drug development.靶向含泛素样、植物同源结构域和指环结构域1(UHRF1)的SET和指环相关(SRA)结构域用于抗癌药物开发。
Oncotarget. 2018 May 25;9(40):26243-26258. doi: 10.18632/oncotarget.25425.
5
Systematic detection of positive selection in the human-pathogen interactome and lasting effects on infectious disease susceptibility.系统性检测人类病原体互作组中的正选择及对传染病易感性的持久影响。
PLoS One. 2018 May 25;13(5):e0196676. doi: 10.1371/journal.pone.0196676. eCollection 2018.
6
The epigenetic integrator UHRF1: on the road to become a universal biomarker for cancer.表观遗传整合因子UHRF1:迈向成为癌症通用生物标志物之路。
Oncotarget. 2017 Apr 24;8(31):51946-51962. doi: 10.18632/oncotarget.17393. eCollection 2017 Aug 1.
7
Clinicopathological analysis of UHRF1 expression in medulloblastoma tissues and its regulation on tumor cell proliferation.髓母细胞瘤组织中UHRF1表达的临床病理分析及其对肿瘤细胞增殖的调控
Med Oncol. 2016 Sep;33(9):99. doi: 10.1007/s12032-016-0799-8. Epub 2016 Jul 23.
8
UHRF1 gene silencing inhibits cell proliferation and promotes cell apoptosis in human cervical squamous cell carcinoma CaSki cells.UHRF1基因沉默抑制人宫颈鳞状细胞癌CaSki细胞的增殖并促进其凋亡。
J Ovarian Res. 2016 Jul 19;9(1):42. doi: 10.1186/s13048-016-0253-8.
9
Identification of key genes for laryngeal squamous cell carcinoma using weighted co-expression network analysis.使用加权共表达网络分析鉴定喉鳞状细胞癌的关键基因
Oncol Lett. 2016 May;11(5):3327-3331. doi: 10.3892/ol.2016.4378. Epub 2016 Mar 24.
Ann Surg Oncol. 2012 Aug;19(8):2753-62. doi: 10.1245/s10434-011-2194-1. Epub 2012 Jan 5.
4
UHRF1 Links the Histone code and DNA Methylation to ensure Faithful Epigenetic Memory Inheritance.UHRF1将组蛋白密码与DNA甲基化联系起来,以确保表观遗传记忆的忠实遗传。
Genet Epigenet. 2010 Jan 14;2009(2):29-36.
5
UHRF1 is associated with tumor recurrence in non-muscle-invasive bladder cancer.UHRF1 与非肌肉浸润性膀胱癌的肿瘤复发相关。
Med Oncol. 2012 Jun;29(2):842-7. doi: 10.1007/s12032-011-9983-z. Epub 2011 May 25.
6
UHRF1-mediated tumor suppressor gene inactivation in nonsmall cell lung cancer.UHRF1 介导的非小细胞肺癌抑癌基因失活。
Cancer. 2011 Mar 1;117(5):1027-37. doi: 10.1002/cncr.25531. Epub 2010 Nov 8.
7
UHRF1 is a novel diagnostic marker of lung cancer.UHRF1 是一种新型肺癌诊断标志物。
Br J Cancer. 2010 Jul 13;103(2):217-22. doi: 10.1038/sj.bjc.6605717. Epub 2010 Jun 1.
8
UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer.UHRF1 与散发性乳腺癌中 BRCA1 的表观遗传沉默有关。
Breast Cancer Res Treat. 2010 Sep;123(2):359-73. doi: 10.1007/s10549-009-0652-2. Epub 2009 Nov 27.
9
Gene expression profiling associated with the progression to poorly differentiated thyroid carcinomas.与进展为低分化甲状腺癌相关的基因表达谱分析
Br J Cancer. 2009 Nov 17;101(10):1782-91. doi: 10.1038/sj.bjc.6605340. Epub 2009 Oct 6.
10
UHRF1 is a novel molecular marker for diagnosis and the prognosis of bladder cancer.UHRF1是一种用于膀胱癌诊断和预后的新型分子标志物。
Br J Cancer. 2009 Jul 7;101(1):98-105. doi: 10.1038/sj.bjc.6605123. Epub 2009 Jun 2.